Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Klimek

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cytokines, Cellular & Molecular Therapy|June 13, 2000
Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapyJ D Wolchok, V M Klimek, L Williams, et al.
Clinics in Plastic Surgery|August 15, 2000
Systemic chemotherapyV M Klimek, J D Wolchok, P B Chapman, et al.
Bone Marrow Transplantation|June 25, 2008
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition diseaseH Hassoun, C Flombaum, V D D'Agati, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cytokines, Cellular & Molecular Therapy|June 13, 2000
Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapyJ D Wolchok, V M Klimek, L Williams, et al.
Clinics in Plastic Surgery|August 15, 2000
Systemic chemotherapyV M Klimek, J D Wolchok, P B Chapman, et al.
Bone Marrow Transplantation|June 25, 2008
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition diseaseH Hassoun, C Flombaum, V D D'Agati, et al.
Pageof 1